Skip to main content
Jonathan Sharrett, DO, Radiation Oncology, Post Falls, ID

JonathanSharrettDO

Radiation Oncology Post Falls, ID

Radiation Oncologist

Dr. Sharrett is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sharrett's full profile

Already have an account?

  • Office

    1641 E Polston Ave
    Ste 102
    Post Falls, ID 83854
    Phone+1 208-755-2804
    Fax+1 208-765-0277

Summary

  • Radiation Oncologist

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Radiation Oncology, 2016 - 2020
  • Edward Via College of Osteopathic Medicine-Carolinas Campus
    Edward Via College of Osteopathic Medicine-Carolinas CampusClass of 2015

Certifications & Licensure

  • ID State Medical License
    ID State License 2020 - 2025
  • WA State Medical License
    WA State License 2020 - 2025
  • OH State Medical License
    OH State License 2016 - 2021
  • American Board of Radiology Radiation Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Treatment Outcomes and Patterns of Failure in High Grade Lymphoma of the Thyroid Following Combined Modality Therapy: Single Institution Series
    J.M. Sharrett1, C.S. Shah2, E.S. Murphy2, A.M. Garcia3, D. Jagadeesh3, R. Dean3, B. Hill3, B. Pohlman3, S. Cherian2, ASTRO 2019, Chicago, IL, 9/15/2019
  • Factors Associated with Recurrence and Death in Patients with Aggressive Tall Cell Papillary Thyroid Cancer: A Large, Single Institution Series
    J.M. Sharrett1, S. Rao2, H. Li3, A. Shah3, C. Nasr3, J.L. Geiger4, J. Scharpf5, S. Koyfman6, N.P. Joshi6, ASTRO 2019, Chicago, IL, 9/1/2019
  • Gender Differences in Clinical Presentation and Treatment Outcomes in Aggressive Tall Cell Papillary Thyroid Carcinoma in A Large, Single Institution Experience
    J.M. Sharrett1, S. Rao2, H. Li3, A. Shah3, C. Nasr3, J.L. Geiger4, J. Scharpf5, S. Koyfman6, N.P. Joshi6, ASTRO 2019, Chicago, IL, 9/1/2019
  • Join now to see all

Lectures

  • Role of Exercise in Mitigating Neurocognitive Decline Following Radiotherapy 
    St. Jude Children's Research Hospital - 8/2019
  • Factors associated with recurrence and death in patients with aggressive hobnail morphology papillary thyroid carcinoma. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Movers & Shakers
    Movers & ShakersNovember 25th, 2021

Professional Memberships